- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2012
- Public Summary Document (PSD) March 2012 PBAC Meeting - PDF
Tapentadol – March 2012
Tapentadol, tablet, 50 mg, 100 mg, 150 mg, 200 mg and 250 mg (as hydrochloride) (sustained release), Palexia SR® - March 2012
Last updated
8 November 2023